Le Lézard
Classified in: Health, Business
Subjects: NPT, LEG, AVO

American Kidney Fund Applauds Introduction of California AB 1223 to Prevent Insurance Discrimination Against Living Organ Donors and Provide Job-Protected Leave


ROCKVILLE, Md., Feb. 22, 2018 /PRNewswire/ -- The nonprofit American Kidney Fund (AKF) commends California Assemblymember Dr. Joaquin Arambula on the introduction of AB 1223, a bill designed to remove obstacles for individuals who wish to be living organ donors. The bill provides 12 weeks of job-protected leave for living organ donation, and prohibits life, disability and long-term care insurance companies from denying or limiting coverage and from charging higher premiums for living organ donors.

American Kidney Fund Logo (PRNewsfoto/American Kidney Fund)

While most transplanted organs are from deceased donors, patients may also receive organs from living donors. Living donation offers an alternative for individuals awaiting transplantation from a deceased donor and increases the existing organ supply. Kidneys are the most common organ transplanted from living donors, followed by liver and lung.

In California today, 19,000 people are on the kidney transplant waiting list. Of the 2,557 kidney transplants performed in California in 2018, 26 percent (663) were from living donors. Nationally, 29 percent of the 22,000 kidney transplants in 2018 came from living donors.

AKF is fighting for legislation like AB 1223 in states across the country and at the federal level because each day, 13 people die while waiting for a kidney transplant. AB 1223 will remove roadblocks to people who are considering becoming living donors.

"We are grateful for Dr. Arambula's recognition of the role the legislature can play in making it easier for living donors to make the decision to give the lifesaving gift of an organ," said LaVarne A. Burton, AKF president and CEO. "The American Kidney Fund has been working to help get this bill introduced because we see every day how transplants transform the lives the patients we serve. Encouraging living donation and removing barriers to living donation are the surest ways to increase the supply of desperately needed kidneys."

AKF provides long-term financial assistance that makes transplants and post-transplant care possible for low-income dialysis patients. In 2018, AKF helped more than 1,000 people nationwide have transplants, including nearly 50 in California. AKF's program helps post-transplant patients for their full insurance plan year, ensuring continuity of care.

About the American Kidney Fund

As the nation's leading independent nonprofit working on behalf of the 30 million Americans with kidney disease, the American Kidney Fund is dedicated to ensuring that every kidney patient has access to health care, and that every person at risk for kidney disease is empowered to prevent it. AKF provides a complete spectrum of programs and services: prevention outreach, top-rated health educational resources, and direct financial assistance enabling low-income dialysis and transplant patients to access lifesaving medical care, including dialysis and transplantation. AKF holds the highest ratings from the nation's charity watchdog groups, including Charity Navigator, which includes AKF on its "top 10" list of nonprofits with the longest track records of outstanding stewardship of the donated dollar, and GuideStar, which has awarded AKF its Platinum Seal of Transparency.

For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter and Instagram.  

 

SOURCE American Kidney Fund


These press releases may also interest you

at 08:15
YETI Holdings, Inc. ("YETI") today announced that it plans to report its first quarter fiscal year 2024 financial results on Thursday, May 9, 2024, before the market opens. YETI will host a conference call at 8:00 a.m. ET to discuss its financial...

at 08:15
AdaptHealth Corp. ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2024 financial...

at 08:15
Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 second quarter ended...

at 08:15
GE Vernova Inc. is scheduled to announce its first quarter 2024 financial results on Thursday, April 25, 2024, before market open. The company will host a webcast to discuss its financial results at 7:30 AM ET, which can be accessed at...

at 08:11
With the fourth block reward halving around the corner for BTC and BSV, there will be increased focus from miners regarding the scaling potential of blockchain technology, with a focus on revenue, cost efficiencies, and sustainability....

at 08:10
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that it will report financial results for the first quarter ending March 31, 2024 on Thursday, May 2, 2024, before the U.S. financial markets open. Management...



News published on and distributed by: